Trademark: 78378648
Status Date
Friday, December 26, 2014
Registration Number
3431115
Registration Date
Tuesday, May 20, 2008
Filing Date
Thursday, March 4, 2004
Published for Opposition
Tuesday, November 8, 2005
Cancellation Date
Friday, December 26, 2014
1 Chemical and biochemical products for use in gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis in gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis in gene delivery technology, micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic variations thereof, all for in vivo use in gene delivery technology and catalysts for gene delivery technology in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease
5 Gene therapy and prophylaxis products, pharmaceutical substances and preparations for use in the medical industry, namely, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; vector production technologies and neurogenomics products in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; Chemical products for use in medical science for the treatment of diseases of the eye, vascular and neo-vascularisition disorders, single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation *and injuries of the nervous, system all* in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease; pharmaceutical and biochemical preparations for the treatment of damaged nerves and spinal injuries and for the induction of nerve re-growth; medical instruments and apparatus for the administration of gene and antibody-based therapy and prophylactics, preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease
In the heading, delete class 42. Statement(s): Column 2, line 2, after "technologies" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" Column 2, line 4, after "products" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" Column 2, line 13 after "vascularisation" "in the fields of disease and injury of the nervous system, including spinal cord injury and disease and peripheral nerve injury and disease" should be inserted.
In the statement, Page 2, Column 1, line 15, after "Vascularisation" and injuries of the nervous, system, all should be inserted.
Dec 26, 2014
Cancelled Sec. 8 (6-Yr)
Jun 1, 2009
Certificate Of Correction Issued
Jan 6, 2009
Assigned To Paralegal
Dec 17, 2008
Teas Change Of Correspondence Received
Dec 17, 2008
Teas Change Of Correspondence Received
Dec 9, 2008
Teas Section 7 Request Received
Sep 15, 2008
Certificate Of Correction Issued
Sep 15, 2008
Assigned To Paralegal
May 20, 2008
Registered-Principal Register
Apr 16, 2008
Ttab Release Case To Trademarks
Apr 16, 2008
Opposition Terminated No. 999999
Apr 16, 2008
Opposition Dismissed No. 999999
Mar 4, 2008
Paper Received
Mar 9, 2006
Opposition Instituted No. 999999
Dec 8, 2005
Extension Of Time To Oppose Received
Nov 8, 2005
Published For Opposition
Oct 19, 2005
Notice Of Publication
Sep 22, 2005
Law Office Publication Review Completed
Sep 16, 2005
Assigned To Lie
Sep 13, 2005
Approved For Pub - Principal Register
Sep 13, 2005
Examiner's Amendment Entered
Sep 13, 2005
Examiners Amendment Mailed
Sep 13, 2005
Examiners Amendment -Written
Sep 9, 2005
Previous Allowance Count Withdrawn
Aug 22, 2005
Withdrawn Before Publication
May 24, 2005
Law Office Publication Review Completed
May 20, 2005
Assigned To Lie
May 17, 2005
Approved For Pub - Principal Register
Mar 23, 2005
Teas/Email Correspondence Entered
Mar 16, 2005
Correspondence Received In Law Office
Mar 16, 2005
Teas Response To Office Action Received
Sep 22, 2004
Non-Final Action Mailed
Sep 21, 2004
Non-Final Action Written
Sep 20, 2004
Assigned To Examiner
Mar 19, 2004
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
